-
Views
-
Cite
Cite
James A. Karlowsky, Clyde Thornsberry, Mark E. Jones, Alan T. Evangelista, Ian A. Critchley, Daniel F. Sahm, Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998–2002), Clinical Infectious Diseases, Volume 36, Issue 8, 15 April 2003, Pages 963–970, https://doi.org/10.1086/374052
- Share Icon Share
Abstract
To identify factors associated with antimicrobial resistance, data were analyzed from 27,828 isolates of Streptococcus pneumoniae submitted to the Tracking Resistance in the United States Today (TRUST) surveillance program during 4 consecutive respiratory seasons. From the 1998–1999 season to the 2001–2002 season, the prevalence of azithromycin resistance increased by 4.8% to 27.5%, the prevalence of penicillin resistance increased by 3.7% to 18.4%, the prevalence of ceftriaxone resistance increased by 0.5% to 1.7%, and the prevalence of levofloxacin resistance increased by 0.3% to 0.9%. Isolates recovered from patients <18 years of age and lower respiratory tract specimens had elevated rates of penicillin, azithromycin, and trimethoprim-sulfamethoxazole resistance (P < .00001); penicillin resistance correlated with coresistance to trimethoprim-sulfamethoxazole (87.3%), azithromycin (76.3%), ceftriaxone (9.1%), and levofloxacin (1.3%) (P < .00001). Only 62 (0.2%) of 27,828 isolates were concurrently resistant to penicillin and levofloxacin. Minimum inhibitory concentrations (MICs) of penicillin correlated strongly with MICs of ceftriaxone (R2 = 0.90), trimethoprim-sulfamethoxazole (R2 = 0.53), and azithromycin (R2 = 0.41). Patient age, specimen source, and penicillin resistance were factors associated with antimicrobial resistance, particularly for nonfluoroquinolone antimicrobial agents.
- ceftriaxone
- azithromycin
- penicillin
- drug resistance, microbial
- penicillin resistance
- respiratory system
- streptococcus pneumoniae
- trimethoprim-sulfamethoxazole combination
- levofloxacin
- antimicrobials
- minimum inhibitory concentration measurement
- surveillance program
- malnutrition-inflammation-cachexia syndrome